ID

37648

Descripción

Study ID: 104864/612 Clinical Study ID: 104864/612 Study Title: A Prospective, Open Label Phase II Study to Evaluate the Efficacy and Safety of Topotecan (HycamtinTM) in Combination with Carboplatin as First-line Chemotherapy in Patients with Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: HycamtinTM Study Indication: Ovarian Cancer

Palabras clave

Versiones (1)
  1. 13/8/19 13/8/19 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

13 de agosto de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Topotecan (HycamtinTM) with Carboplatin as First-Line Chemotherapy in Patients with Ovarian Cancer; 104864/612

Inglés

Cycle 7

1 formularios  
  1. StudyEvent: ODM
    1. Cycle 7
Administrative Data
Descripción

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient Number
Descripción

Patient number

Tipo de datos

integer

Alias
UMLS CUI [1]
C1830427
Day 1-5
Descripción

Day 1-5

Alias
UMLS CUI-1
C0008976
UMLS CUI-2
C0449438
Has the cycle been delayed?
Descripción

Clinical Trials, Delay of chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1299577
If Yes, please document the reason
Descripción

Clinical Trials, Delay of chemotherapy, Reason and justification

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1299577
UMLS CUI [1,3]
C0566251
Please specify
Descripción

Clinical Trials, Delay of chemotherapy, Reason and justification

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1299577
UMLS CUI [1,3]
C0566251
Administration of study medication topotecan (oral)
Descripción

Administration of study medication topotecan (oral)

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0146224
UMLS CUI-3
C3469597
Day
Descripción

Experimental drug, Topotecan, Administration of medication, Day

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C3469597
UMLS CUI [1,4]
C0439228
Date
Descripción

Experimental drug, Topotecan, Administration of medication, Date in time

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C3469597
UMLS CUI [1,4]
C0011008
Planned daily dose for this cycle
Descripción

Experimental drug, Topotecan, Daily Dose, Planned

Tipo de datos

text

Unidades de medida
  • mg/m2
Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C2348070
UMLS CUI [1,4]
C1301732
Administered dose for this cycle
Descripción

Experimental drug, Topotecan, Dosage

Tipo de datos

integer

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0178602
mg
Administration of study medication topotecan (oral)
Descripción

Administration of study medication topotecan (oral)

Alias
UMLS CUI-1
C0304229
UMLS CUI-2
C0146224
UMLS CUI-3
C3469597
Capsules dispensed on
Descripción

Experimental drug, Topotecan, Dispense, Date in time

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1880359
UMLS CUI [1,4]
C0011008
Number of 1 mg capsules
Descripción

Experimental drug, Topotecan, Capsule, Dispensed Amount

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C0805077
Number of 0,25 mg capsules
Descripción

Experimental drug, Topotecan, Capsule, Dispensed Amount

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C0805077
Capsules returned by the patient on
Descripción

Experimental drug, Topotecan, Returned, Date in time

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0332156
UMLS CUI [1,4]
C0011008
Number of 1 mg capsules
Descripción

Experimental drug, Topotecan, Capsule, Returned Amount

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C2699071
Number of 0,25 mg capsules
Descripción

Experimental drug, Topotecan, Capsule, Returned Amount

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C0006935
UMLS CUI [1,4]
C2699071
Has the dose been modified when compared to the previous cycle?
Descripción

Experimental drug, Topotecan, Medication dose changed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1608430
If "yes", please document the reason
Descripción

Experimental drug, Topotecan, Medication dose changed, Reason and justification

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1608430
UMLS CUI [1,4]
C0566251
Please specify
Descripción

Experimental drug, Topotecan, Medication dose changed, Reason and justification

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0146224
UMLS CUI [1,3]
C1608430
UMLS CUI [1,4]
C0566251
Volver a la parte superior de la página

Similar models

Cycle 7

1 formularios
  1. StudyEvent: ODM
    1. Cycle 7
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Patient number
Item
Patient Number
integer
C1830427 (UMLS CUI [1])
Item Group
Day 1-5
C0008976 (UMLS CUI-1)
C0449438 (UMLS CUI-2)
Clinical Trials, Delay of chemotherapy
Item
Has the cycle been delayed?
boolean
C0008976 (UMLS CUI [1,1])
C1299577 (UMLS CUI [1,2])
Item
If Yes, please document the reason
text
C0008976 (UMLS CUI [1,1])
C1299577 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Clinical Trials, Delay of chemotherapy, Reason and justification
Code List
If Yes, please document the reason
CL Item
hematological AE (1)
CL Item
non-hematological AE (2)
CL Item
Other, please specify (3)
Item
Please specify
text
C0008976 (UMLS CUI [1,1])
C1299577 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Clinical Trials, Delay of chemotherapy, Reason and justification
Code List
Please specify
Item Group
Administration of study medication topotecan (oral)
C0304229 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C3469597 (UMLS CUI-3)
Item
Day
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C3469597 (UMLS CUI [1,3])
C0439228 (UMLS CUI [1,4])
Experimental drug, Topotecan, Administration of medication, Day
Code List
Day
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
Experimental drug, Topotecan, Administration of medication, Date in time
Item
Date
date
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C3469597 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Item
Planned daily dose for this cycle
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C2348070 (UMLS CUI [1,3])
C1301732 (UMLS CUI [1,4])
Laboratory Procedures, Hematology finding, Visit
Code List
Planned daily dose for this cycle
CL Item
Baseline (1)
CL Item
Day 1 (2)
CL Item
Day 8 (3)
CL Item
Day 15 (4)
Experimental drug, Topotecan, Dosage
Item
Administered dose for this cycle
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
Item Group
Administration of study medication topotecan (oral)
C0304229 (UMLS CUI-1)
C0146224 (UMLS CUI-2)
C3469597 (UMLS CUI-3)
Experimental drug, Topotecan, Dispense, Date in time
Item
Capsules dispensed on
date
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1880359 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Dispensed Amount
Item
Number of 1 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Dispensed Amount
Item
Number of 0,25 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0805077 (UMLS CUI [1,4])
Experimental drug, Topotecan, Returned, Date in time
Item
Capsules returned by the patient on
date
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0332156 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Returned Amount
Item
Number of 1 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
Experimental drug, Topotecan, Capsule, Returned Amount
Item
Number of 0,25 mg capsules
integer
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C2699071 (UMLS CUI [1,4])
Experimental drug, Topotecan, Medication dose changed
Item
Has the dose been modified when compared to the previous cycle?
boolean
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
Item
If "yes", please document the reason
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
Experimental drug, Topotecan, Medication dose changed, Reason and justification
Code List
If "yes", please document the reason
CL Item
hematological AE (1)
CL Item
non-hematological AE (2)
CL Item
Other, please specify (3)
Experimental drug, Topotecan, Medication dose changed, Reason and justification
Item
Please specify
text
C0304229 (UMLS CUI [1,1])
C0146224 (UMLS CUI [1,2])
C1608430 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial